|
Diabetes, Vol 42, Issue 5 643-650, Copyright © 1993 by American Diabetes Association
The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains
MG Myers and MF White
Research Division, Joslin Diabetes Center, Boston, MA 02215.
Since the discovery of insulin and its receptor, the downstream elements
responsible for the pleiotropic insulin signal have been difficult to
define. The recently discovered insulin receptor substrate, IRS-1, provides
an innovative and simple way to think about this problem: IRS-1 may mediate
the control of various cellular processes by insulin. Overexpression of
IRS-1 enhances insulin-stimulated DNA synthesis in Chinese hamster ovary
cells, and microinjection of IRS-1 protein potentiates the maturation of
Xenopus oocytes. We suspect that insulin signals are enabled when the
activated insulin receptor kinase phosphorylates specific tyrosine residues
in IRS-1. These phosphorylated sites associate with high affinity to
cellular proteins that contain SH2 (src homology-2) domains. This
association is specific and depends on the amino acid sequence surrounding
the phosphotyrosine residue and the isoform of the SH2 domain. A growing
number of SH2 domain-containing proteins have been identified, and we
suspect that IRS-1 has the potential to simultaneously regulate many of
them. We have only begun to identify the specific proteins that associate
with phosphorylated IRS-1. One of them, the phosphatidylinositol 3'-kinase,
is activated when the SH2 domains in its 85,000-M(r) regulatory subunit
bind to phosphorylated IRS-1. IRS-1 also interacts with other proteins such
as SHPTP2, a novel SH2 domain-containing Tyr phosphatase, and GRB-2/sem-5,
a protein that is implicated in p21ras signaling. The interaction between
phosphorylated IRS-1 and multiple SH2 domain-containing proteins may
ultimately explain the pleiotropic effects of insulin.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Giraud, M. Haas, E. P. Feener, K. D. Copps, X. Dong, S. L. Dunn, and M. F. White
Phosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling
Mol. Endocrinol.,
September 1, 2007;
21(9):
2294 - 2302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Pandey, X. X. Yu, L. M. Watts, M. D. Michael, K. W. Sloop, A. R. Rivard, T. A. Leedom, V. P. Manchem, L. Samadzadeh, R. A. McKay, et al.
Reduction of Low Molecular Weight Protein-tyrosine Phosphatase Expression Improves Hyperglycemia and Insulin Sensitivity in Obese Mice
J. Biol. Chem.,
May 11, 2007;
282(19):
14291 - 14299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Guo, S. L. Dunn, and M. F. White
The Reciprocal Stability of FOXO1 and IRS2 Creates a Regulatory Circuit that Controls Insulin Signaling
Mol. Endocrinol.,
December 1, 2006;
20(12):
3389 - 3399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Castillo, I. Ammendrup-Johnsen, M. Codina, I. Navarro, and J. Gutierrez
IGF-I and insulin receptor signal transduction in trout muscle cells
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2006;
290(6):
R1683 - R1690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Sentinelli, E Filippi, M G Cavallo, S Romeo, M Fanelli, and M G Baroni
The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPAR{gamma} agonist restores normal cell signaling and differentiation
J. Endocrinol.,
February 1, 2006;
188(2):
271 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Deng, S. Bhattacharya, O. R. Swamy, R. Tandon, Y. Wang, R. Janda, and H. Riedel
Growth Factor Receptor-binding Protein 10 (Grb10) as a Partner of Phosphatidylinositol 3-Kinase in Metabolic Insulin Action
J. Biol. Chem.,
October 10, 2003;
278(41):
39311 - 39322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wang, V. L. DeGroff, and S. K. Clinton
Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase
J. Nutr.,
July 1, 2003;
133(7):
2367 - 2376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tardif, N. Julien, J.-L. Chiasson, and L. Coderre
Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation
Am J Physiol Endocrinol Metab,
June 1, 2003;
284(6):
E1055 - E1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. White
IRS proteins and the common path to diabetes
Am J Physiol Endocrinol Metab,
September 1, 2002;
283(3):
E413 - E422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tack, S. J. Elliot, M. Potier, A. Rivera, G. E. Striker, and L. J. Striker
Autocrine Activation of the IGF-I Signaling Pathway in Mesangial Cells Isolated From Diabetic NOD Mice
Diabetes,
January 1, 2002;
51(1):
182 - 188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Fadool, K. Tucker, J. J. Phillips, and J. A. Simmen
Brain Insulin Receptor Causes Activity-Dependent Current Suppression in the Olfactory Bulb Through Multiple Phosphorylation of Kv1.3
J Neurophysiol,
April 1, 2000;
83(4):
2332 - 2348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M. F. White
The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307
J. Biol. Chem.,
March 17, 2000;
275(12):
9047 - 9054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kausch, A. Hamann, I. Uphues, A. Niendorf, D. Müller-Wieland, H.-G. Joost, P. Algenstaedt, M. Dreyer, H. W. Rüdiger, H.-U. Häring, et al.
Association of Impaired Phosphatidylinositol 3-Kinase Activity in GLUT1-Containing Vesicles with Malinsertion of Glucose Transporters into the Plasma Membrane of Fibroblasts from a Patient with Severe Insulin Resistance and Clinical Features of Werner Syndrome
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
905 - 918.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Delafontaine
IRS-1 Variant : A New Risk Factor for Coronary Artery Disease?
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2000;
20(2):
283 - 284.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uchida, M. G. Myers Jr., and M. F. White
IRS-4 Mediates Protein Kinase B Signaling during Insulin Stimulation without Promoting Antiapoptosis
Mol. Cell. Biol.,
January 1, 2000;
20(1):
126 - 138.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. G. Baroni, M. P. D’Andrea, A. Montali, G. Pannitteri, F. Barilla, F. Campagna, E. Mazzei, S. Lovari, F. Seccareccia, P. P. Campa, et al.
A Common Mutation of the Insulin Receptor Substrate-1 Gene Is A Risk Factor for Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol.,
December 1, 1999;
19(12):
2975 - 2980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. Solow, S. Harada, B. J. Goldstein, J. A. Smith, M. F. White, and L. Jarett
Differential Modulation of the Tyrosine Phosphorylation State of the Insulin Receptor by IRS (Insulin Receptor Subunit) Proteins
Mol. Endocrinol.,
October 1, 1999;
13(10):
1784 - 1798.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Heikkinen, M. Pietila, M. Halmekyto, S. Suppola, E. Pirinen, S. S. Deeb, J. Janne, and M. Laakso
Hexokinase II-deficient Mice. PRENATAL DEATH OF HOMOZYGOTES WITHOUT DISTURBANCES IN GLUCOSE TOLERANCE IN HETEROZYGOTES
J. Biol. Chem.,
August 6, 1999;
274(32):
22517 - 22523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Wang, A. Almahfouz, F. Giorgino, K. C. McCowen, and R. J. Smith
In Vivo Insulin Signaling in the Myocardium of Streptozotocin-Diabetic Rats: Opposite Effects of Diabetes on Insulin Stimulation of Glycogen Synthase and c-Fos
Endocrinology,
March 1, 1999;
140(3):
1141 - 1150.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-O. Contreres, R. Faure, G. Baquiran, J. J. Bergeron, and B. I. Posner
ATP-dependent Desensitization of Insulin Binding and Tyrosine Kinase Activity of the Insulin Receptor Kinase. THE ROLE OF ENDOSOMAL ACIDIFICATION
J. Biol. Chem.,
August 21, 1998;
273(34):
22007 - 22013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Agati, D. Yeagley, and P. G. Quinn
Assessment of the Roles of Mitogen-activated Protein Kinase, Phosphatidylinositol 3-Kinase, Protein Kinase B, and Protein Kinase C in Insulin Inhibition of cAMP-induced Phosphoenolpyruvate Carboxykinase Gene Transcription
J. Biol. Chem.,
July 24, 1998;
273(30):
18751 - 18759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Sung, W. S. Choi, and V. Sanchez-Margalet
Guanosine Triphosphatase-Activating Protein-Associated Protein, But Not src-Associated Protein p68 in Mitosis, Is a Part of Insulin Signaling Complexes
Endocrinology,
May 1, 1998;
139(5):
2392 - 2398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Kao, S. B. Waters, S. Okada, and J. E. Pessin
Insulin Stimulates the Phosphorylation of the 66- and 52-Kilodalton Shc Isoforms by Distinct Pathways
Endocrinology,
June 1, 1997;
138(6):
2474 - 2480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Beitner-Johnson, V. A. Blakesley, Z. Shen-Orr, M. Jimenez, B. Stannard, L.-M. Wang, J. Pierce, and D. LeRoith
The Proto-oncogene Product c-Crk Associates with Insulin Receptor Substrate-1 and 4PS
J. Biol. Chem.,
April 19, 1996;
271(16):
9287 - 9290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kharitonenkov, Jür. Schnekenburger, Z. Chen, P. Knyazev, S. Ali, E. Zwick, M. White, and A. Ullrich
Adapter Function of Protein-tyrosine Phosphatase 1D in Insulin Receptor/Insulin Receptor Substrate-1 Interaction
J. Biol. Chem.,
December 8, 1995;
270(49):
29189 - 29193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stein-Gerlach, A. Kharitonenkov, W. Vogel, S. Ali, and A. Ullrich
Protein-tyrosine Phosphatase 1D Modulates Its Own State of Tyrosine Phosphorylation
J. Biol. Chem.,
October 20, 1995;
270(42):
24635 - 24637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. H. Møller, K. B. Møller, R. Lammers, A. Kharitonenkov, E. Hoppe, F. C. Wiberg, I. Sures, and A. Ullrich
Selective Down-regulation of the Insulin Receptor Signal by Protein-tyrosine Phosphatases alpha and [IMAGE]
J. Biol. Chem.,
September 29, 1995;
270(39):
23126 - 23131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Okada, K. Yamauchi, and J. E. Pessin
Shc Isoform-specific Tyrosine Phosphorylation by the Insulin and Epidermal Growth Factor Receptors
J. Biol. Chem.,
September 1, 1995;
270(35):
20737 - 20741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamauchi, V. Ribon, A. R. Saltiel, and J. E. Pessin
Identification of the Major SHPTP2-binding Protein That Is Tyrosine-phosphorylated in Response to Insulin
J. Biol. Chem.,
July 28, 1995;
270(30):
17716 - 17722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Beitner-Johnson and D. LeRoith
Insulin-like Growth Factor-I Stimulates Tyrosine Phosphorylation of Endogenous c-Crk
J. Biol. Chem.,
March 10, 1995;
270(10):
5187 - 5190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Siemeister, H. Al-Hasani, H. W. Klein, S. Kellner, Rüd. Streicher, W. Krone, and D. Müller-Wieland
Recombinant Human Insulin Receptor Substrate-1 Protein
J. Biol. Chem.,
March 3, 1995;
270(9):
4870 - 4874.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1993 by the American Diabetes Association.
|
|
| |
|